Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?

被引：19
|
作者：
Edwards, B. [1 ]
Andini, R. [2 ]
Esposito, S. [3 ]
Grossi, P. [4 ]
Lew, D. [5 ]
Mazzei, T. [6 ]
Novelli, A. [6 ]
Soriano, A. [7 ]
Gould, I. M. [8 ]
机构：
[1] Royal Infirm Edinburgh NHS Trust, Dept Med Microbiol, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Univ Naples 2, AORN Monaldi, UOC Transplant & Infect Dis Med, Naples, Italy
[3] Univ Salerno, Dept Med, I-84100 Salerno, Italy
[4] Univ Unisubria, Dept Surg & Morphol Studies, Varese, Italy
[5] Univ Hosp Geneva, Chief Dept Specialties Internal Med, Chief Infect Dis Div, Geneva, Switzerland
[6] Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Sect, Florence, Italy
[7] Hosp Clin Barcelona, IDIBAPS, Dept Infect Dis, Barcelona, Spain
[8] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen, Scotland
来源：
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE | 2014年 / 2卷 / 03期
关键词：
MRSA; Treatment; Susceptibility testing; MINIMUM INHIBITORY CONCENTRATION; HIGH-DOSE DAPTOMYCIN; BLOOD-STREAM INFECTIONS; LINEZOLID-ASSOCIATED THROMBOCYTOPENIA; CONTINUOUS VENOVENOUS HEMOFILTRATION; VANCOMYCIN-INTERMEDIATE RESISTANCE; CRITICALLY-ILL PATIENTS; SOFT-TISSUE INFECTIONS; CONTINUOUS-INFUSION; EXPERIMENTAL ENDOCARDITIS;
D O I：
10.1016/j.jgar.2014.03.009
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) infection continues to be a substantial global problem with significant associated morbidity and mortality. This review summarises the discussions that took place at the 4th MRSA Consensus Conference in relation to the current treatment options for serious MRSA infections and how to optimise whichever therapy is embarked upon. It highlights the many challenges faced by both the laboratory and clinicians in the diagnosis and treatment of MRSA infections. (C) 2014 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：133 / 140
页数：8
相关论文
共 50 条
  • [41] Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin
    Sharma, Roopali
    Hammerschlag, Margaret R.
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2019, 21 (10)
  • [42] Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Children: a Reappraisal of Vancomycin
    Roopali Sharma
    Margaret R. Hammerschlag
    [J]. Current Infectious Disease Reports, 2019, 21
  • [43] A SURVEY OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ( MRSA) TREATMENT IN CYSTIC FIBROSIS PATIENTS
    Manasco, K. B.
    Newsom, L.
    McKie, K. T.
    [J]. PEDIATRIC PULMONOLOGY, 2013, 48 : 314 - 315
  • [44] Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
    Brown, Nicholas M.
    Brown, Erwin M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (06) : 1377 - 1378
  • [45] Endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA):: Treatment failure with linezolid
    Ruiz, ME
    Guerrero, I
    Tuazon, C
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1179 - 1179
  • [46] Exposure Mapping of Antimicrobials for the Treatment of Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia
    Caffrey, Aisling R.
    Noh, Eunsun
    LaPlante, Kerry L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 205 - 205
  • [47] New cephalosporin as an alternative for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)
    Batista, Bruna Gerardon
    Rauber, Janine de Melo
    Bruschi, Jaine Stypulsowski
    d'Azevedo, Pedro Alves
    [J]. REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO, 2015, 5 (02): : 94 - 99
  • [48] Treatment Options of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection: Medical Education
    Kaya, Selcuk
    [J]. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2008, 28 (06): : 956 - 961
  • [49] Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
    Hooper, Candace Y.
    Smith, Winter J.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 131 - 137
  • [50] Exploring the Benefits of Metal Ions in Phage Cocktail for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
    Li, Xinxin
    Chen, Yibao
    Wang, Shuang
    Duan, Xiaochao
    Zhang, Fenqiang
    Guo, Aizhen
    Tao, Pan
    Chen, Huanchun
    Li, Xiangmin
    Qian, Ping
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 2689 - 2702
12345